Near-term anti-CD25 monoclonal antibody administration protects murine liver from ischemia-reperfusion injury due to reduced numbers of CD4+T cells

PLoS ONE

Volumn 9, Issue 9, 2014, Pages

  Yang, Jinghui ^a   Wang, Xiaoyu ^a   Song, Shaohua ^a   Liu, Fang ^a   Fu, Zhiren ^a   Wang, Quanxing ^b  

^a SECOND MILITARY MEDICAL UNIVERSITY   (China)

^b SECOND MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

BASILIXIMAB; GAMMA INTERFERON; IMMUNOGLOBULIN G; INTERLEUKIN 2; INTERLEUKIN 6; MESSENGER RNA; TUMOR NECROSIS FACTOR ALPHA; INTERLEUKIN 2 RECEPTOR ALPHA; MONOCLONAL ANTIBODY; PC61 MONOCLONAL ANTIBODY;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CD4 LYMPHOCYTE COUNT; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL EXPANSION; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE ASSOCIATION; DRUG EFFECT; ENZYME BLOOD LEVEL; GENE EXPRESSION; IFN GAMMA GENE; IL 2 GENE; IL 6 GENE; LIVER INJURY; LIVER ISCHEMIA; LIVER PROTECTION; LYMPHOCYTE PROLIFERATION; LYMPHOCYTE SUBPOPULATION; MALE; MOUSE; NONHUMAN; POSITIVE FEEDBACK; PROTEIN EXPRESSION; REGULATORY T LYMPHOCYTE; REPERFUSION INJURY; T LYMPHOCYTE ACTIVATION; TNF ALPHA GENE; ANIMAL; ANTAGONISTS AND INHIBITORS; C57BL MOUSE; CELL PROLIFERATION; DRUG EFFECTS; GENETICS; IMMUNOLOGY; IMMUNOMODULATION; IMMUNOPHENOTYPING; LIVER; PATHOLOGY; PRIMARY CELL CULTURE; TIME;

MURINAE;

ANIMALS; ANTIBODIES, MONOCLONAL; CD4 LYMPHOCYTE COUNT; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CELL PROLIFERATION; GENE EXPRESSION; IMMUNOMODULATION; IMMUNOPHENOTYPING; INTERFERON-GAMMA; INTERLEUKIN-2; INTERLEUKIN-2 RECEPTOR ALPHA SUBUNIT; INTERLEUKIN-6; LIVER; MALE; MICE; MICE, INBRED C57BL; PRIMARY CELL CULTURE; REPERFUSION INJURY; TIME FACTORS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84907058820     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0106892     Document Type: Article

References (36)

1. Datta G, Fuller BJ, Davidson BR (2013) Molecular mechanisms of liver ischemia reperfusion injury: Insights from transgenic knockout models. World J Gastroenterol 19: 1683-1698.
2. Fondevila C, Busuttil RW, Kupiec-Weglinski JW (2003) Hepatic ischemia/reperfusion injury-a fresh look. Exp Mol Pathol 74: 86-93.
3. Huang Y, Rabb H, Womer KL (2007) Ischemia-reperfusion and immediate T cell responses. Cell Immunol 248: 4-11.
4. Burne MJ, Daniels F, El Ghandour A, Mauiyyedi S, Colvin RB, et al. (2001) Identification of the CD4(+) T cell as a major pathogenic factor in ischemic acute renal failure. J Clin Invest 108: 1283-1290.
5. Burne-Taney MJ, Liu M, Baldwin WM, Racusen L, Rabb H (2006) Decreased capacity of immune cells to cause tissue injury mediates kidney ischemic preconditioning. J Immunol 176: 7015-7020.
6. Kinsey GR, Sharma R, Huang L, Li L, Vergis AL, et al. (2009) Regulatory T cells suppress innate immunity in kidney ischemia-reperfusion injury. J Am Soc Nephrol 20: 1744-1753.
7. Horie Y, Wolf R, Chervenak RP, Jennings SR, Granger DN (1999) T-lymphocytes contribute to hepatic leukostasis and hypoxic stress induced by gut ischemia-reperfusion. Microcirculation 6: 267-280.
8. Hardinger KL, Brennan DC, Klein CL (2012) Selection of induction therapy in kidney transplantation. Transpl Int.
9. Rochman Y, Spolski R, Leonard WJ (2009) New insights into the regulation of T cells by gamma(c) family cytokines. Nat Rev Immunol 9: 480-490.
10. Johnston JA, Bacon CM, Riedy MC, O'Shea JJ (1996) Signaling by IL-2 and related cytokines: JAKs, STATs, and relationship to immunodeficiency. J Leukoc Biol 60: 441-452.
11. Devey LR, Richards JA, O'Connor RA, Borthwick G, Clay S, et al. (2012) Ischemic preconditioning in the liver is independent of regulatory T cell activity. PLoS One 7: e49647.
12. Yang X, Bai H, Wang Y, Li J, Zhou Q, et al. (2013) Deletion of regulatory T cells supports the development of intestinal ischemia-reperfusion injuries. J Surg Res 184: 832-837.
13. Rabb H (2002) The T cell as a bridge between innate and adaptive immune systems: implications for the kidney. Kidney Int 61: 1935-1946.
14. Dostert C, Ludigs K, Guarda G (2013) Innate and adaptive effects of inflammasomes on T cell responses. Curr Opin Immunol 25: 359-365.
15. Casey KA, Fraser KA, Schenkel JM, Moran A, Abt MC, et al. (2012) Antigen-independent differentiation and maintenance of effector-like resident memory T cells in tissues. J Immunol 188: 4866-4875.
16. +T cells on the fate of allografts in the absence of immunosuppression. Transplantation 79: 648-654.
17. Meier-Kriesche HU, Schold JD, Srinivas TR, Kaplan B (2004) Lack of improvement in renal allograft survival despite a marked decrease in acute rejection rates over the most recent era. Am J Transplant 4: 378-383.
18. Adu D, Cockwell P, Ives NJ, Shaw J, Wheatley K (2003) Interleukin-2 receptor monoclonal antibodies in renal transplantation: meta-analysis of randomised trials. BMJ 326: 789.
19. Webster AC, Playford EG, Higgins G, Chapman JR, Craig JC (2004) Interleukin 2 receptor antagonists for renal transplant recipients: a meta-analysis of randomized trials. Transplantation 77: 166-176.
20. Turner AP, Knechtle SJ (2013) Induction immunosuppression in liver transplantation: a review. Transpl Int 26: 673-683.
21. Outerelo C, Gouveia R, Mateus A, Cruz P, Oliveira C, et al. (2013) Induction therapy with basiliximab and full HLA mismatch. Transplant Proc 45: 1076-1078.
22. de Sandes-Freitas TV, Felipe CR, de Franco MF, Tedesco-Silva H, Medina- Pestana JO (2013) Basiliximab induction in patients receiving tacrolimus-based immunosuppressive regimens. Int Urol Nephrol 45: 537-546.
23. Martin-Mateos RM, Graus J, Albillos A, Arocena C, Rodriguez Gandia MA, et al. (2012) Initial immunosuppression with or without basiliximab: a comparative study. Transplant Proc 44: 2570-2572.
24. Huang P, Huo Y, Lou LX, Li H, Barnstable CJ, et al. (2013) CD4 positive T helper cells contribute to retinal ganglion cell death in mouse model of ischemia reperfusion injury. Exp Eye Res 115: 131-139.
25. de Perrot M, Young K, Imai Y, Liu M, Waddell TK, et al. (2003) Recipient T cells mediate reperfusion injury after lung transplantation in the rat. J Immunol 171: 4995-5002.
26. Friedewald JJ, Rabb H (2004) Inflammatory cells in ischemic acute renal failure. Kidney Int 66: 486-491.
27. Gandolfo MT, Rabb H (2007) Very early alloantigen-independent trafficking of lymphocytes during ischemic acute kidney injury. Kidney Int 71: 1193-1195.
28. +T cells contribute to postischemic liver injury in mice by interacting with sinusoidal endothelium and platelets. Hepatology 43: 306-315.
29. Leite-De-Moraes MC, Hameg A, Arnould A, Machavoine F, Koezuka Y, et al. (1999) A distinct IL-18-induced pathway to fully activate NK T lymphocytes independently from TCR engagement. J Immunol 163: 5871-5876.
30. van Golen RF, van Gulik TM, Heger M (2012) The sterile immune response during hepatic ischemia/reperfusion. Cytokine Growth Factor Rev 23: 69-84.
31. Kim MG, Koo TY, Yan JJ, Lee E, Han KH, et al. (2013) IL-2/anti-IL-2 complex attenuates renal ischemia-reperfusion injury through expansion of regulatory T cells. J Am Soc Nephrol 24: 1529-1536.
32. +regulatory T cells enhances the antigen-specific primary and memory CTL response elicited by mature mRNA-electroporated dendritic cells. Mol Ther 12: 922-932.
33. Tanaka T, Narazaki M, Kishimoto T (2012) Therapeutic targeting of the interleukin-6 receptor. Annu Rev Pharmacol Toxicol 52: 199-219.
34. Zwacka RM, Zhang Y, Halldorson J, Schlossberg H, Dudus L, et al. (1997) CD4(+) T-lymphocytes mediate ischemia/reperfusion-induced inflammatory responses in mouse liver. J Clin Invest 100: 279-289.
35. Li P, Mao L, Zhou G, Leak RK, Sun BL, et al. (2013) Adoptive regulatory T-cell therapy preserves systemic immune homeostasis after cerebral ischemia. Stroke 44: 3509-3515.
36. Brea D, Agulla J, Rodriguez-Yanez M, Barral D, Ramos-Cabrer P, et al. (2014) Regulatory T cells modulate inflammation and reduce infarct volume in experimental brain ischaemia. J Cell Mol Med.